DK3680243T3 - Pentacyklisk forbindelse - Google Patents

Pentacyklisk forbindelse Download PDF

Info

Publication number
DK3680243T3
DK3680243T3 DK18853415.0T DK18853415T DK3680243T3 DK 3680243 T3 DK3680243 T3 DK 3680243T3 DK 18853415 T DK18853415 T DK 18853415T DK 3680243 T3 DK3680243 T3 DK 3680243T3
Authority
DK
Denmark
Prior art keywords
pentacyclic
connection
pentacyclic connection
Prior art date
Application number
DK18853415.0T
Other languages
English (en)
Inventor
Yoshiaki Ohashi
Yoshihiko Norimine
Tamaki HOSHIKAWA
Yu Yoshida
Yoshihisa Kobayashi
Nobuhiro Sato
Koji Hagiwara
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of DK3680243T3 publication Critical patent/DK3680243T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK18853415.0T 2017-09-07 2018-09-05 Pentacyklisk forbindelse DK3680243T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017172169 2017-09-07
PCT/JP2018/032797 WO2019049869A1 (ja) 2017-09-07 2018-09-05 五環式化合物

Publications (1)

Publication Number Publication Date
DK3680243T3 true DK3680243T3 (da) 2022-01-10

Family

ID=65517037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18853415.0T DK3680243T3 (da) 2017-09-07 2018-09-05 Pentacyklisk forbindelse

Country Status (34)

Country Link
US (1) US10239889B1 (da)
EP (1) EP3680243B1 (da)
JP (1) JP6557441B1 (da)
KR (1) KR102307738B1 (da)
CN (1) CN111051316B (da)
AR (1) AR112788A1 (da)
AU (1) AU2018330578B2 (da)
CA (1) CA3072740A1 (da)
CL (1) CL2020000376A1 (da)
CO (1) CO2020001471A2 (da)
CY (1) CY1125355T1 (da)
DK (1) DK3680243T3 (da)
ES (1) ES2903172T3 (da)
HR (1) HRP20220019T1 (da)
HU (1) HUE056791T2 (da)
IL (1) IL272652B (da)
JO (1) JOP20200030B1 (da)
LT (1) LT3680243T (da)
MA (1) MA50093B1 (da)
MD (1) MD3680243T2 (da)
MX (1) MX2020001786A (da)
PE (1) PE20200860A1 (da)
PH (1) PH12020500341A1 (da)
PL (1) PL3680243T3 (da)
PT (1) PT3680243T (da)
RS (1) RS62796B1 (da)
RU (1) RU2754557C1 (da)
SG (1) SG11202001240XA (da)
SI (1) SI3680243T1 (da)
SM (1) SMT202200004T1 (da)
TW (1) TWI707859B (da)
UA (1) UA125940C2 (da)
WO (1) WO2019049869A1 (da)
ZA (2) ZA202000970B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002611A (es) 2017-09-07 2020-07-13 Univ Res Inst Inc Augusta Activador especifico de akt3 y usos del mismo.
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药（上海）有限公司 环烯烃取代的杂芳环类化合物及其用途
EP3936190A4 (en) * 2019-03-05 2022-11-16 Eisai R&D Management Co., Ltd. PENTACYCLIC HETEROCYCLIC COMPOUND
CA3129764A1 (en) * 2019-03-05 2020-09-10 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof
EP4069369A4 (en) * 2019-12-06 2024-02-14 Schrödinger, Inc. CYCLIC COMPOUNDS AND METHODS OF USE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187306A (en) 1977-07-26 1980-02-05 Bayer Aktiengesellschaft Benzodiazepine-diones, a process for their production and their use as medicaments
DD258234A1 (de) * 1987-03-05 1988-07-13 Univ Leipzig Verfahren zur herstellung von pyrido/3',2':4,5/thieno/2,3-e/imidazo-/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidine
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
TW197442B (da) * 1990-02-08 1993-01-01 Pfizer
KR100203456B1 (ko) * 1995-06-20 1999-06-15 한승수 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제
FR2779652B1 (fr) * 1998-06-15 2001-06-08 Sod Conseils Rech Applic Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
MX2007004640A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物

Also Published As

Publication number Publication date
US10239889B1 (en) 2019-03-26
MA50093B1 (fr) 2022-05-31
JOP20200030A1 (ar) 2020-02-12
KR20200051585A (ko) 2020-05-13
CA3072740A1 (en) 2019-03-14
EP3680243B1 (en) 2021-10-27
CY1125355T1 (el) 2024-02-16
HRP20220019T1 (hr) 2022-04-01
JOP20200030B1 (ar) 2025-10-01
US20190071452A1 (en) 2019-03-07
PE20200860A1 (es) 2020-08-25
IL272652B (en) 2022-09-01
EP3680243A4 (en) 2021-01-06
PT3680243T (pt) 2022-01-12
JP6557441B1 (ja) 2019-08-07
ZA202000970B (en) 2021-07-28
SMT202200004T1 (it) 2022-03-21
KR102307738B1 (ko) 2021-10-05
CO2020001471A2 (es) 2020-05-29
WO2019049869A1 (ja) 2019-03-14
TWI707859B (zh) 2020-10-21
LT3680243T (lt) 2021-11-25
UA125940C2 (uk) 2022-07-13
PL3680243T3 (pl) 2022-02-14
EP3680243A1 (en) 2020-07-15
AU2018330578B2 (en) 2022-11-10
RS62796B1 (sr) 2022-02-28
CL2020000376A1 (es) 2020-08-28
AU2018330578A1 (en) 2020-02-27
ZA202007737B (en) 2025-04-30
RU2754557C1 (ru) 2021-09-03
NZ761699A (en) 2025-07-25
MD3680243T2 (ro) 2022-05-31
PH12020500341A1 (en) 2020-10-05
ES2903172T3 (es) 2022-03-31
SG11202001240XA (en) 2020-03-30
TW201920195A (zh) 2019-06-01
CN111051316A (zh) 2020-04-21
JPWO2019049869A1 (ja) 2019-11-07
CN111051316B (zh) 2022-05-31
MX2020001786A (es) 2022-09-13
BR112020003197A2 (pt) 2020-09-29
MA50093A (fr) 2021-05-05
AR112788A1 (es) 2019-12-11
IL272652A (en) 2020-03-31
SI3680243T1 (sl) 2022-01-31
HUE056791T2 (hu) 2022-03-28

Similar Documents

Publication Publication Date Title
IL271227A (en) Image sensor structure
DK3731771T3 (da) V462033dk00
EP3549340A4 (en) MULTI-HYPOTHESIS FUSION MODE
CL2018000524S1 (es) Golilla
EP3589248A4 (en) CRYOTHERAPIES
DE202018003363U8 (de) Handgelenkssphygmomanometer
EP3634404C0 (en) PYRAZOLE-BASED MAGL INHIBITORS
EP3588580A4 (en) SCHOTTKY MOS TRENCH DIODE
DK3351526T3 (da) Diisopentylterephthalat
EP3654852A4 (en) TOURNIQUET
EP3634397A4 (en) HETEROCYCLYL POLYMETHINE-BASED IR CHROMOPHORES
DK3568655T3 (da) Rekuperator
DK3571580T5 (da) Load-logical-and-shift-guarded-instruktion
DK3464336T3 (da) Forbindelser
DK3612237T3 (da) Genterapi
EP3437786A4 (en) Joint structure
EP3611402A4 (en) SERVO CYLINDER
EP3615471A4 (en) PLASMA PHOTOELECTRONIC IMMUNE SENSOR
DK3438103T3 (da) Griseofulvinforbindelse
EP3490399A4 (en) INTERCONNECTS
LT3680243T (lt) Pentaciklinis junginys
DK3576686T3 (da) Brokbind
DK3568506T3 (da) Offeranode
EP3438473A4 (en) CONNECTION STRUCTURE
EP3607993A4 (en) INTERCONNECTS